Issue 98, 2021

Reversing tumor multidrug resistance with a catalytically active covalent organic framework

Abstract

We report here a catalytically active nano covalent organic framework [COF(Fe)] with high drug loading capacity for reversing tumor multidrug resistance (MDR). The Fe catalytic sites in COF(Fe) could convert intracellular overexpressed H2O2 into highly reactive ˙OH to induce oxidation stress and down-regulate MDR protein. Therefore, COF(Fe) could enhance the intracellular drug accumulation to overcome MDR, which was demonstrated both in vitro and in vivo.

Graphical abstract: Reversing tumor multidrug resistance with a catalytically active covalent organic framework

Supplementary files

Article information

Article type
Communication
Submitted
11 Aug 2021
Accepted
11 Nov 2021
First published
11 Nov 2021

Chem. Commun., 2021,57, 13309-13312

Reversing tumor multidrug resistance with a catalytically active covalent organic framework

P. Gao, T. Zheng, B. Cui, X. Liu, W. Pan, N. Li and B. Tang, Chem. Commun., 2021, 57, 13309 DOI: 10.1039/D1CC04414A

To request permission to reproduce material from this article, please go to the Copyright Clearance Center request page.

If you are an author contributing to an RSC publication, you do not need to request permission provided correct acknowledgement is given.

If you are the author of this article, you do not need to request permission to reproduce figures and diagrams provided correct acknowledgement is given. If you want to reproduce the whole article in a third-party publication (excluding your thesis/dissertation for which permission is not required) please go to the Copyright Clearance Center request page.

Read more about how to correctly acknowledge RSC content.

Social activity

Spotlight

Advertisements